Citations (19)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Steve Elliott & Angus M Sinclair. (2012) The effect of erythropoietin on normal and neoplastic cells. Biologics: Targets and Therapy 6, pages 163-189.
Read now
Read now
Giuseppe Lauria, Angela Campanella, Graziella Filippini, Alfredo Martini, Paola Penza, Lorenzo Maggi, Carlo Antozzi, Claudia Ciano, Pinuccia Beretta, Dario Caldiroli, Filippo Ghelma, Giovanni Ferrara, Pietro Ghezzi & Renato Mantegazza. (2009) Erythropoietin in amyotrophic lateral sclerosis: A pilot, randomized, double-blind, placebo-controlled study of safety and tolerability. Amyotrophic Lateral Sclerosis 10:5-6, pages 410-415.
Read now
Read now
Articles from other publishers (17)
William M. Pardridge. (2023) Treatment of Parkinson’s disease with biologics that penetrate the blood–brain barrier via receptor-mediated transport. Frontiers in Aging Neuroscience 15.
Crossref
Crossref
Yousra El Ouaamari, Jasper Van den Bos, Barbara Willekens, Nathalie Cools & Inez Wens. (2023) Neurotrophic Factors as Regenerative Therapy for Neurodegenerative Diseases: Current Status, Challenges and Future Perspectives. International Journal of Molecular Sciences 24:4, pages 3866.
Crossref
Crossref
Federica Rey, Alice Balsari, Toniella Giallongo, Sara Ottolenghi, Anna M. Di Giulio, Michele Samaja & Stephana Carelli. (2019) Erythropoietin as a Neuroprotective Molecule: An Overview of Its Therapeutic Potential in Neurodegenerative Diseases. ASN Neuro 11, pages 175909141987142.
Crossref
Crossref
Giuseppe Lauria, Eleonora Dalla Bella, Giovanni Antonini, Giuseppe Borghero, Margherita Capasso, Claudia Caponnetto, Adriano Chiò, Massimo Corbo, Roberto Eleopra, Raffaella Fazio, Massimiliano Filosto, Fabio Giannini, Enrico Granieri, Vincenzo La Bella, Giancarlo Logroscino, Jessica Mandrioli, Letizia Mazzini, Maria Rosaria Monsurrò, Gabriele Mora, Vladimiro Pietrini, Rocco Quatrale, Romana Rizzi, Fabrizio Salvi, Gabriele Siciliano, Gianni Sorarù, Paolo Volanti, Irene Tramacere & Graziella Filippini. (2015) Erythropoietin in amyotrophic lateral sclerosis: a multicentre, randomised, double blind, placebo controlled, phase III study. Journal of Neurology, Neurosurgery & Psychiatry 86:8, pages 879-886.
Crossref
Crossref
Marta Ruiz, Ana Fe Martínez-Vidal, José Manuel Morales, Daniel Monleón & Minerva Giménez y Ribotta. (2014) Neurodegenerative changes are prevented by Erythropoietin in the pmn model of motoneuron degeneration. Neuropharmacology 83, pages 137-153.
Crossref
Crossref
Hyun Young KimChanil MoonKyung Suk KimKi Wook OhSeong-il OhJuhan KimSeung Hyun Kim. (2014) Recombinant Human Erythropoietin in Amyotrophic Lateral Sclerosis: A Pilot Study of Safety and Feasibility. Journal of Clinical Neurology 10:4, pages 342.
Crossref
Crossref
Ping K. Yip, Chiara Pizzasegola, Stacy Gladman, Maria Luigia Biggio, Marianna Marino, Maduka Jayasinghe, Farhan Ullah, Simon C. Dyall, Andrea Malaspina, Caterina Bendotti & Adina Michael-Titus. (2013) The Omega-3 Fatty Acid Eicosapentaenoic Acid Accelerates Disease Progression in a Model of Amyotrophic Lateral Sclerosis. PLoS ONE 8:4, pages e61626.
Crossref
Crossref
Kenneth Maiese, Zhao Zhong Chong, Yan Chen Shang & Shaohui Wang. (2012) Erythropoietin: New Directions for the Nervous System. International Journal of Molecular Sciences 13:9, pages 11102-11129.
Crossref
Crossref
Erica A. Dale, Irawan Satriotomo & Gordon S. Mitchell. (2012) Cervical Spinal Erythropoietin Induces Phrenic Motor Facilitation via Extracellular Signal-Regulated Protein Kinase and Akt Signaling. The Journal of Neuroscience 32:17, pages 5973-5983.
Crossref
Crossref
William M. Pardridge & Ruben J. Boado. 2012. Protein Engineering for Therapeutics, Part B. Protein Engineering for Therapeutics, Part B
269
292
.
Goang-Won Cho, Ga-Young Kim, Soojeong Baek, Heejaung Kim, Taikon Kim, Hee Jin Kim & Seung Hyun Kim. (2011) Recombinant human erythropoietin reduces aggregation of mutant Cu/Zn-binding superoxide dismutase (SOD1) in NSC-34 cells. Neuroscience Letters 504:2, pages 107-111.
Crossref
Crossref
Qing-Hui Zhou, Eric Ka-Wai Hui, Jeff Zhiqiang Lu, Ruben J. Boado & William M. Pardridge. (2011) Brain penetrating IgG-erythropoietin fusion protein is neuroprotective following intravenous treatment in Parkinson's disease in the mouse. Brain Research 1382, pages 315-320.
Crossref
Crossref
Derya Sargin, Heidi Friedrichs, Ahmed El-Kordi & Hannelore Ehrenreich. (2010) Erythropoietin as neuroprotective and neuroregenerative treatment strategy: Comprehensive overview of 12 years of preclinical and clinical research. Best Practice & Research Clinical Anaesthesiology 24:4, pages 573-594.
Crossref
Crossref
Angus M. SinclairAngela CoxonIan McCaffery, Stephen Kaufman, Katherine Paweletz, Liqin LiuLeigh BusseSusan SwiftSteven ElliottC. Glenn Begley. (2010) Functional erythropoietin receptor is undetectable in endothelial, cardiac, neuronal, and renal cells. Blood 115:21, pages 4264-4272.
Crossref
Crossref
P. Janik, H. Kwiecinski, B. Sokolowska & I. Niebroj-Dobosz. (2009) Erythropoietin concentration in serum and cerebrospinal fluid of patients with amyotrophic lateral sclerosis. Journal of Neural Transmission 117:3, pages 343-347.
Crossref
Crossref
Claudia Bartels, Kira Späte, Henning Krampe & Hannelore Ehrenreich. (2008) Review: Recombinant human erythropoietin: novel strategies for neuroprotective/neuroregenerative treatment of multiple sclerosis. Therapeutic Advances in Neurological Disorders 1:3, pages 193-206.
Crossref
Crossref
Patrick O. Butsch & Merit E. Cudkowicz. (2007) Is erythropoietin a potential therapy for amyotrophic lateral sclerosis?. Experimental Neurology 206:1, pages 11-15.
Crossref
Crossref